Ertapenem in the treatment of multidrug-resistant tuberculosis: First clinical experience

European Respiratory Journal

Volumn 47, Issue 1, 2016, Pages 333-336

  Tiberi, Simon ^a   D'Ambrosio, Lia ^b,c   Lorenzo, Saverio De ^d   Viggiani, Pietro ^d   Centis, Rosella ^c   Sotgiu, Giovanni ^e   Alffenaar, Jan Wilem C ^f   Migliori, Giovanni Battista ^c  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b Public Health Consulting Group SAGL   (Switzerland)

^c IRCCS   (Italy)

^d AOVV   (Italy)

^e UNIVERSITY OF SASSARI   (Italy)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BEDAQUILINE; CAPREOMYCIN; ERTAPENEM; IMIPENEM; ISONIAZID; KANAMYCIN; MEROPENEM; QUINOLONE DERIVATIVE; RIFAMPICIN; ANTIINFECTIVE AGENT; BETA LACTAM; TUBERCULOSTATIC AGENT;

ANTIBIOTIC SENSITIVITY; DISEASE SEVERITY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; LETTER; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPUTUM SMEAR; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT; ADULT; COMBINATION DRUG THERAPY; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; BETA-LACTAMS; DRUG THERAPY, COMBINATION; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84954287886     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01278-2015     Document Type: Letter

References (15)

1. World Health Organization. Global tuberculosis report 2014. WHO/HTM/TB2014.08. Geneva, World Health Organization, 2014.
2. Falzon D, Jaramillo E, Schunemann HJ, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38: 516-528.
3. Falzon D, Gandhi N, Migliori GB, et al. Resistance to fluoroquinolones and second-line injectable drugs: Impact on multidrug-resistant TB outcomes. Eur Respir J 2013; 42: 156-168.
4. Migliori GB, Sotgiu G, Gandhi NR, et al. Drug resistance beyond extensively drug-resistant tuberculosis: Individual patient data meta-analysis. Eur Respir J 2013; 42: 169-179.
5. Blasi F, Dara M, van der Werf MJ, et al. Supporting TB clinicians managing difficult cases: The ERS/WHO Consilium. Eur Respir J 2013; 41: 491-494.
6. Diel R, Vandeputte J, de Vries G, et al. Costs of tuberculosis disease in the European Union: A systematic analysis and cost calculation. Eur Respir J 2014; 43: 554-565.
7. De Lorenzo S, Alffenaar JW, Sotgiu G, et al. Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB. Eur Respir J 2013; 41: 1386-1392.
8. Cordillot M, Dubee V, Triboulet S, et al. In vitro cross-linking of Mycobacterium tuberculosis peptidoglycan by L,D-transpeptidases and inactivation of these enzymes by carbapenems. Antimicrob Agents Chemother 2013; 57: 5940-5945.
9. Tremblay LW, Fan F, Blanchard JS. Biochemical and structural characterization of Mycobacterium tuberculosis beta-lactamase with the carbapenems ertapenem and doripenem. Biochemistry 2010; 49: 3766-3773.
10. De Lorenzo S, Centis R, D'Ambrosio L, et al. On linezolid efficacy and tolerability. Eur Respir J 2012; 39: 770-772.
11. Sotgiu G, Centis R, D'Ambrosio L, et al. Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: Systematic review and meta-analysis. Eur Respir J 2012; 40: 1430-1442.
12. Srivastava S, Peloquin CA, Sotgiu G, et al. Therapeutic drug management: Is it the future of multidrug-resistant tuberculosis treatment Eur Respir J 2013; 42: 1449-1453.
13. Tiberi S, De Lorenzo S, Centis R, et al. Bedaquiline in MDR/XDR-TB cases: first experience on compassionate use. Eur Respir J 2014; 43: 289-292.
14. Esposito S, D'Ambrosio L, Tadolini M, et al. ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: Case study of compassionate delamanid use. Eur Respir J 2014; 44: 811-815.
15. Sotgiu G, D'Ambrosio L, Centis R, et al. TB and M/XDR-TB infection control in European TB reference centres: The Achilles' heel Eur Respir J 2011; 38: 1221-1223.